CAMKK2 and lymphoma: We next leveraged the EG7-OVA lymphoma model to determine the ability of WT and Camkk2-/- mice to develop a specific T cell-mediated response toward the OVA antigen, which is selectively expressed by E.G7-OVA lymphoma cells.